Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Cardiovascular Pharmacology
|
January 5, 2022
Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients With Heart Failure With Reduced Ejection Fraction
Po-Wei Chen, Ashit Trivedi, Edward Lee, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 4, 2020
Performance of longitudinal item response theory models in shortened or partial assessments
Leticia Arrington, Sebastian Ueckert, Malidi Ahamadi, et al.
The AAPS Journal
|
June 2, 2025
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
Bingyu Mao, Yue Gao, Christine Xu, et al.
The AAPS Journal
|
November 18, 2025
Opportunities for AI-based Model-informed Drug Development: A Comparative Analysis of NONMEM and AI-based Models for Population Pharmacokinetic Prediction
Bingyu Mao, Yue Gao, Christine Xu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 24, 2022
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma
Malidi Ahamadi, Johannes Kast, Po-Wei Chen, et al.
Journal of Pharmaceutical Sciences
|
April 21, 2012
Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption
Sebastian Polak, Cyrus Ghobadi, Himanshu Mishra, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 19, 2023
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine
Po-Wei Chen, Mats O Karlsson, Sebastian Ueckert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
When Survival Improves But Quality of Life Does Not: A Model-Based Meta-Analysis of Immune Checkpoint Inhibitors
Yimeng Sun, Shiwon Chang, Kayden Tang, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2017
Evaluation of dosing strategy for pembrolizumab for oncology indications
Tomoko Freshwater, Anna Kondic, Malidi Ahamadi, et al.
Clinical and Translational Science
|
June 9, 2022
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development
Johannes Kast, Saeideh Nozohouri, Di Zhou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Cardiovascular Pharmacology
|
January 5, 2022
Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients With Heart Failure With Reduced Ejection Fraction
Po-Wei Chen, Ashit Trivedi, Edward Lee, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 4, 2020
Performance of longitudinal item response theory models in shortened or partial assessments
Leticia Arrington, Sebastian Ueckert, Malidi Ahamadi, et al.
The AAPS Journal
|
June 2, 2025
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
Bingyu Mao, Yue Gao, Christine Xu, et al.
The AAPS Journal
|
November 18, 2025
Opportunities for AI-based Model-informed Drug Development: A Comparative Analysis of NONMEM and AI-based Models for Population Pharmacokinetic Prediction
Bingyu Mao, Yue Gao, Christine Xu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 24, 2022
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma
Malidi Ahamadi, Johannes Kast, Po-Wei Chen, et al.
Journal of Pharmaceutical Sciences
|
April 21, 2012
Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption
Sebastian Polak, Cyrus Ghobadi, Himanshu Mishra, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 19, 2023
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine
Po-Wei Chen, Mats O Karlsson, Sebastian Ueckert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
When Survival Improves But Quality of Life Does Not: A Model-Based Meta-Analysis of Immune Checkpoint Inhibitors
Yimeng Sun, Shiwon Chang, Kayden Tang, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2017
Evaluation of dosing strategy for pembrolizumab for oncology indications
Tomoko Freshwater, Anna Kondic, Malidi Ahamadi, et al.
Clinical and Translational Science
|
June 9, 2022
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development
Johannes Kast, Saeideh Nozohouri, Di Zhou, et al.
Page
of 3